Marine Invertebrate Antimicrobial Peptides and Their Potential as Novel Peptide Antibiotics

52Citations
Citations of this article
97Readers
Mendeley users who have this article in their library.

Abstract

Marine invertebrates constantly interact with a wide range of microorganisms in their aquatic environment and possess an effective defense system that has enabled their existence for millions of years. Their lack of acquired immunity sets marine invertebrates apart from other marine animals. Invertebrates could rely on their innate immunity, providing the first line of defense, survival, and thriving. The innate immune system of marine invertebrates includes various biologically active compounds, and specifically, antimicrobial peptides. Nowadays, there is a revive of interest in these peptides due to the urgent need to discover novel drugs against antibiotic-resistant bacterial strains, a pressing global concern in modern healthcare. Modern technologies offer extensive possibilities for the development of innovative drugs based on these compounds, which can act against bacteria, fungi, protozoa, and viruses. This review focuses on structural peculiarities, biological functions, gene expression, biosynthesis, mechanisms of antimicrobial action, regulatory activities, and prospects for the therapeutic use of antimicrobial peptides derived from marine invertebrates.

Cite

CITATION STYLE

APA

Guryanova, S. V., Balandin, S. V., Belogurova-Ovchinnikova, O. Y., & Ovchinnikova, T. V. (2023, October 1). Marine Invertebrate Antimicrobial Peptides and Their Potential as Novel Peptide Antibiotics. Marine Drugs. Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/md21100503

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free